Benmassaoud A; Al-Taweel T; Sasson MS; Moza D; Strohl M; Kopylov U; Paradis-Suprenant L; Almaimani M; Bitton A Afif W; Lakatos, Péter László; Bessissow T
(2018)
Direct head-to-head studies comparing the long-term outcomes of infliximab (IFX) to adalimumab (ADA) in Crohn's disease (CD) are sparse.